The pandemic of extended-spectrum-beta-lactamase (ESBL)-producing-Enterobacteriaceae (Ent) is strongly linked to the dissemination of CTX-M-type-ESBL-Ent. We sought to define the epidemiology of infections in children due to an emerging resistance type, CTX-M-9-group-producing-Ent (CTX-M-9-grp-Ent).
Introduction
The pandemic of multi-drug resistant (MDR) Enterobacteriaceae remains one of the most significant public health threats of our time 1, 2 . MDR Enterobacteriaceae are associated with significant morbidity and mortality in infected individuals, and an increasing number of reports describe extra-intestinal and invasive infections with these organisms in children [3] [4] [5] . Many studies show that beta-lactamase (bla) genes harbored by Enterobacteriaceae, e.g. extendedspectrum beta-lactamases (ESBLs or blaESBLs) and carbapenemases (e.g., blaKPCs), are the major contributors to this growing problem 6, 7 . Strains carrying bla genes often harbor additional antibiotic resistance determinants residing on mobile genetic elements, e.g. plasmids and transposons, which are capable of rapid dissemination 1, 7 .
In the U.S. and worldwide, the CTX-M-type ESBL producing Enterobacteriaceae (CTX-M Ent) are the predominant ESBL-producing strains, with the clonal multi-locus sequence type (ST) 131 E. coli harboring CTX-M-15 (CTX-M-1 group) being the most commonly reported in both adult and pediatric studies 7, 8 . However, several other CTX-M types continue to circulate in Ent, and are equally concerning, highly resistant pathogens that can be acquired in the community 9 .
A notable example is the widespread CTX-M-9-group ESBL genes (e.g. blaCTX-M-9, blaCTX-M- 14, which are the most common CTX-M genes circulating in Ent in some geographic regions 10 . A 2016 U.S. study of prevalence of CTX-M genes in Enterobacteriaceae found relative stability of blaCTX-M-15 in E. coli. Nevertheless, an increase in the prevalence of blaCTX-M-14 in E. coli occurred (25.6% and 20.4% in 2013 and 2014) compared to 2012 (16.0%) 11 . Despite this, much less is reported concerning the epidemiology of CTX-M-9-group infections. Unlike the clonal ST131 E. coli strains, CTX-M-9-group genes are associated with multiple strain types and horizontal gene transfer via mobile genetic elements likely plays an important role in their dissemination 12 . While studies of ESBL-Ent in U.S. children and internationally have reported infections due to CTX-M-9-group-producing Enterobacteriaceae (CTX-M-9-grp-Ent) 10, 13 , pediatric studies have not focused on the clinical and molecular epidemiology and impact of infections specifically due to CTX-M-9-grp-Ent.
In previous investigations, the genetic basis for beta-lactam resistance in Enterobacteriaceae isolates recovered from children cared for by multiple centers in the Chicago area was determined 13 . Subsequently, subgroups of children with infections due to similar resistance determinants, (e.g. plasmid-mediated fluoroquinolone, ESBL, and carbapenem resistance genes) were analyzed in order to determine genotypes, host factors, and exposures associated with specific MDR Enterobacteriaceae strains 13, 14 . A prior analysis of children with plasmid-mediated fluoroquinolone-resistant (PMFQR)-Ent infections that there are genetic and geospatial community links to MDR in our pediatric population was found 15 . Here we report that CTX-M-9-grp-Ent infections in children are similarly linked to geographic location, and that acquisition of CTX-M-9-grp-Ent in children demonstrates environmental influences and originates in the community.
METHODS

Study Setting
Hospital A contains a 115-bed children's hospital which includes pediatric and psychiatric wards, a mother-newborn infant unit, and cardiac, neonatal and pediatric intensivecare units (CICU, NICU and PICU), located within a tertiary care academic medical center.
Hospital B is a free-standing children's academic medical center comprised of 288 beds and provides quaternary care services, including bone marrow and organ transplantation. Hospital C is a 125-bed children's hospital within an academic medical center, has newborn infant and general pediatrics wards, as well as a NICU and PICU. The participating centers are all located within metropolitan Chicago.
Descriptive Study Design
Study Population
Patients included in this study were children aged 0 to 20.99 years who were identified 
Antibiotic Susceptibility Testing in Enterobacteriaceae Isolates
The clinical microbiology laboratories of Hospitals A-C phenotypically analyzed ESC-R isolates by the Vitek 2 microbial identification system (bioMérieux, Athens, GA) or via the MicroScan WalkAway system (Beckman Coulter, Brea, CA). Following Clinical and Laboratory Standards Institute (CLSI) guidelines, one or more of the following antimicrobials: aztreonam, ceftriaxone, ceftazidime, cefotaxime or cefpodoxime were used to screen for ESBL production 16 . Techniques used to confirm ESBL production included automated instruments or disk diffusion assays (BBL; Becton, Dickinson and Company, Sparks, MD) to measure cefotaxime and ceftazidime susceptibility in the presence and absence of clavulanic acid. An increase in measure of a disk zone diameter of > 5 mm or a 4-fold reduction in the minimum inhibitory concentration (MIC) of cefotaxime and ceftazidime in the presence of clavulanic acid served as confirmation of the ESBL phenotype 16 .
Molecular Analysis
Beta-Lactam Resistance Determinants
Genomic DNA from Enterobacteriaceae isolates was purified from isolates confirmed with an ESBL phenotype (DNeasy blood and tissue kit, Qiagen, Inc. Valencia, CA). DNA Microarray (Check-MDR CT101 and CT103XL; Check-Points, Wageningen, Netherlands) and polymerase chain reaction (PCR) was performed to assess and confirm the presence of bla genes in isolates as previously described and according to manufacturer protocol 13, 17 . Isolates found to be positive solely for beta-lactamase genes belonging to CTX-M-9-grp were included in the analysis.
Nomenclature and Characterization
A well-established multiplex PCR-based method was used to assign E. coli to one of four phylogenetic groups (A, B1, B2 and D) 18 . Multi-locus sequence typing (MLST) [Pasteur website (http://www.pasteur.fr/recherche/genopole/PF8/mlst/)] and DNA sequencing identified sequence types and PCR distinguished blaCTX-M-9-grp alleles in the ESBL-producing strains of E. coli and Klebsiella species as previously described 13, 19, 20 . Plasmids were typed based on incompatibility groups corresponding to the nomenclature assigned by Carattoli et al. 21 
Analytic Study Design
A retrospective case-control study design was used to assess factors associated with infection due to isolates in which we had detected a blaCTX-M-9-grp gene. Children serving as control subjects were identified using hospital electronic laboratory records (ELRs) and were matched 3:1 to the cases by age range, hospital, and specimen source, a design previously described 22, 23 . Only children diagnosed with clinical infections due to bacteria susceptible to extended-spectrum cephalosporins (ESC-S) were included, as determined by study investigator case review and/or using standard criteria defined by the CDC National Healthcare Safety Network 24 .
Covariates
We analyzed several variables as potential factors associated with CTX-M-9-grp-Ent infection based on known associations for ESBL-producing Enterobacteriaceae acquisition in adults and children including (1) 
Statistical Analysis
We examined case and control groups for differences using parametric or non-parametric tests as appropriate for categorical and continuous variables; a p-value of <0.05 was considered statistically significant unless otherwise specified. Bivariate analysis was performed and variables with p<0.1 were included in multivariable analysis. To assess the multivariable relationship between the covariates and the groups, stepwise multiple logistic regression was employed. The simplest model was included in the final multivariable logistic regression with significant covariates (p<0.05) from the stepwise selection process, with CTX-M-9-grp-Ent infection as the outcome variable. The simplest model was chosen based on a relatively small sample size and the effect of variables in the model. All analyses were performed in SAS 9.4 (SAS Institute, Cary, NC, USA).
RESULTS
Of 356 pediatric Enterobacteriaceae isolates found to harbor 350 bla genes between 2011 -2016, 44 (12.4%) were positive by DNA microarray and PCR amplification solely for blaCTX-M-9-grp genes. Most (91%) CTX-M-9-grp-Ent infections, and a significantly lesser fraction (58%) of ESC-S infections, were E. coli, p=0.003 (Table 1) . Urine was the most common source of CTX-M-9-grp-Ent (70%); differences in the source of infection between groups were not observed.
The antimicrobial susceptibility testing results of CTX-M-9-grp-Ent are summarized in Table 2 .
The highest retained susceptibility was to amikacin, carbapenems and piperacillin-tazobactam.
Multi-drug resistance (resistance to >3 antibiotic classes) was found in 77% of case isolates.
Molecular analysis
Of E. coli, 60% belonged to phylogenetic group D; the rest belonged to B2. Both are virulent phylogroups associated with extra-intestinal pathogenic E. coli infections. Of CTX-M-9-group, the most common subtypes were CTX-M-14 (61%) and CTX-M-27 (34%). MLST revealed diverse strain types. Of the 10 ST types associated with 40 CTX-M-9 E. coli, 25% were ST8; ST43/ST131 and ST506 were the next most common (20% and 15%, respectively). Two novel E. coli strain types were also discovered to carry blaCTX-M-9-grp (data not shown).
Analysis of Factors Associated with CTX-M-9 Ent Infection
The 44 cases of CTX-M-9-grp-Ent infection were matched to 135 ESC-S controls. On bivariate analysis (Table 3) During model building stages, we did not find evidence of significant effect modification or significant confounding; therefore, additional covariates were not added back to the final model after the stepwise selection process was completed, and the simplest model with significant covariates was included in the final regression model.
In the multivariable regression analysis (Table 4) , factors associated with CTX-M-9-grp-Ent infection included having infection due to E. coli (OR 7.0; 95% CI 2.2, 22.2; p<0.001); being of a race or ethnicity "other" (OR 6.5; 95% CI 1.7, 24.3; p=0.002); and being diagnosed in the outpatient clinic setting (OR 4.5; 95% CI 1.7, 11.9; p=0.003).
Remarkably, among children with Enterobacteriaceae infections, those residing in the
South region of Chicago demonstrated more than six times the odds of having a CTX-M-9-grp-Ent infection compared to those living in the reference West Chicago region (OR 6.7; 95% CI 1.2, 37.7; p=0.02) after controlling for race, infecting organism, and healthcare setting. In contrast, for children who resided in the Northwest region, there was an 81% decrease in the odds of CTX-M-9-grp-Ent infection compared to those residing in the reference West Chicago region (OR 0.19; 95% CI 0.04, 0.84; p=0.02). Residence in the Southwest region (the neighboring region to the South region) was also significant for increased likelihood of CTX-M-9-grp infection on bivariate analysis (OR 2.8; 95% CI 1.02, 7.6; p=0.04).
DISCUSSION
Our analysis is the first multi-centered study to assess the clinical and molecular epidemiology of CTX-M-9 type ESBL-producing Enterobacteriaceae infections in children located in an urban setting. We found that E. coli was the most common infecting organism associated with blaCTX-M-9-grp. The CTX-M-9 group are thought to be the second most commonly community-acquired ESBL genes in Enterobacteriaceae worldwide, and, similar to the high-risk clonal ST131 CTX-M-15 producing E. coli, are reported in people without significant healthcare exposure and are associated with multiple antibiotic gene cassettes leading to MDR 3, 9 . However, unlike the association of CTX-M-1 group with ST131, we found that blaCTX-M-9-grp genes are carried by multiple strain types, including the identification of novel STs associated with pediatric infection.
Because of multiple associated strain types carrying blaCTX-M-9-grp genes, we hypothesized that there is significant horizontal gene transfer occurring between genera. Plasmid replicon typing of isolates also supports this hypothesis, as multiple plasmids of different types were found present in isolates from the "high-risk" South region, with Inc F plasmids (FII, FIA, FIB) being the most common (data not shown). This observation is concerning as children once colonized with MDR Enterobacteriaceae can remain colonized for months to years, and young children (median age 4.1 years) were carrying organisms with multiple plasmids, capable of rapid dissemination and spread 13, 25 . Additionally, we found novel ST types carrying blaCTX-M-9grp genes. This portends a troublesome epidemiology suggesting the acquisition of these genes may be occurring in commensal or previously non-pathogenic strains of Enterobacteriaceae.
In our study, most (77%) CTX-M-9-grp-Ent isolates were phenotypically MDR. While the highest retained antibiotic susceptibility included piperacillin-tazobactam, clinicians should be cautioned in its use for serious, invasive infections (e.g. bacteremia). Recent randomized clinical trials have demonstrated inferiority of piperacillin-tazobactam to carbapenem therapy when used to treat ESC-R Ent bloodstream infections (including ESBL-producers) and describe worse patient outcomes associated with piperacillin-tazobactam use as definitive therapy 26 . Of additional concern, susceptibility to oral agents was significantly reduced leaving few oral options for step-down therapy for children ( Table 2 ). The sole oral exception was nitrofurantoin (97% sensitivity) which can be used to treat uncomplicated lower urinary tract infection but should not be used for complicated, invasive infections or acute pyelonephritis, due to the inability of the drug to attain therapeutic levels in the renal parenchyma and bloodstream 27 .
The residential differences for children infected with CTX-M-9-grp-Ent compared to children infected with antibiotic sensitive strains was striking. We found a substantial increase in odds of infection with the resistant strains in south Chicago region, and a significant decrease in odds of infection in the northwest Chicago region. Our study included 3 major pediatric centers, none of which are located in the "high-risk" South region, yet all three centers diagnosed and treated patients with CTX-M-9-grp-Ent infections from these high-risk regions. The reservoirs associated with acquisition of CTX-M-9-grp-Ent in these regions are currently undefined.
Of additional concern, in a separate study of plasmid-mediated fluoroquinolone resistant (PMFQR) Ent infections in children between 2011-2014, we found a substantial increase in odds of PMFQR Ent infection in the Southwest region, while in the Downtown region (comprising the downtown Chicago area, near North side, Chicago loop, and North Chicago) there was a significant decrease in the likelihood of PMFQR Ent infection 15 . These PMFQR Ent "high-risk" and "low-risk" regions neighbor the "high-risk" South region and "low-risk" Northwest region in the current study. The Southwest region was found to be associated with an increase in the odds of CTX-M-9-grp-Ent infection on bivariate analysis in this study, though this did not reach statistical significance on multivariable analysis once controlling for other variables.
Furthermore, we found that children with CTX-M-9-grp-Ent infection were significantly more likely to present in the outpatient clinic setting compared to those with antibiotic susceptible Ent infections. This is surprising and striking as most infections caused by MDROs in the U.S. are linked to healthcare settings 28 . While the majority of infections were associated with virulent extra-intestinal-pathogenic E. coli phylogenetic groups (B and D), these data suggest that CTX-M-9-grp-Ent infections in children are being acquired in the community and may be less severe at presentation as children presented more often in outpatient clinics. This is in stark contrast to the epidemiology of MDR Enterobacteriaceae infections reported in adults in Chicago, where acquisition has been strongly associated with residence in long-term care facilities and the interfacility transfer of patients 29 .
The higher likelihood of CTX-M-9-grp-Ent infection in those of non-white, non-black, and non-Hispanic race was an additional association discovered on multivariable analysis. This risk was statistically independent of residence, and only one of the children located in the "high risk" south region was of race "other", supporting the independence of the two risk factors for infection. We were unable to gather further data on "other" race or ethnicity due to the retrospective nature of the study, and we did not have travel data for the majority of children. It is well described that travel to certain countries can be associated with high rates of ESBL Ent acquisition, particularly in South and Southeast Asia 30 . It is also well described that there is an increased risk of colonization when residing in a household with a family member with history of ESBL Ent or who acquired such a strain during travel to an endemic region 31 .
Environmental influences originating in the community could include higher risks in certain populations due to specific exposures to foods, animals, water sources, fertilizer, soil, and vegetation 32 . We did not have data on companion pets for the majority of children and were unable to examine this risk factor; though pets may play a significant role in human acquisition of antibiotic resistant bacteria 33 . Lastly, we did not find overall differences in a general comparison of socioeconomic status of the "high risk" south region and neighboring regions such as the southwest and west regions using regional zip codes and Illinois census data.
We recognize the limitations of our study. This was a retrospective study of children with Enterobacteriaceae infections in a single metropolitan area which may affect generalizability to other regions. While selection bias may result from small sample sizes, the pooling of multicentered data from institutions of differing types in the 3rd largest U.S. metropolitan area and serving diverse populations potentially lessens this bias. Moreover, our sample size is consistent with the overall low prevalence of these MDR Enterobacteriaceae children in the majority of the U.S. (1-3%) including Chicago and the Midwest region 34, 35 ; however, it should be noted that national trends indicate an increase in the incidence and prevalence of pediatric MDR Enterobacteriaceae over the last decade, an emerging threat that needs further assessment 5, 36 .
In conclusion, we describe, for the first time, community origins of CTX-M-9-grp Enterobacteriaceae in children, and the impact of residence on infection in children located in the same geographic area. The reservoirs associated with CTX-M-9-grp-Ent infections remain undefined. Future studies must focus on environmental influences associated with regional acquisition. "Silent dissemination" of community-acquired MDR Enterobacteriaceae is likely occurring in children outside of healthcare settings. Dedicated programs on a local, national and global scale must focus on children and halting of spread of these dangerous pathogens. 
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